Caricamento...
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
Coronavirus disease 2019 (COVID-19) first emerged in late 2019 in China. At the time of writing, its causative agent SARS-CoV-2 has spread worldwide infecting over 9 million individuals and causing more than 460,000 deaths. In the absence of vaccines, we are facing the dramatic challenge of controll...
Salvato in:
| Pubblicato in: | Cytokine Growth Factor Rev |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Ltd.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7334951/ https://ncbi.nlm.nih.gov/pubmed/32665127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cytogfr.2020.07.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|